Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 923-201-3 | CAS number: 1192143-92-2
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- adopted in 1987
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Landesinstitut für Arbeitsschutz und Produktsicherheit, München, Germany
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- UMA121
- IUPAC Name:
- UMA121
- Reference substance name:
- Propanol, oxybis-, oligomeric reaction products with 1,1'-methylenebis[isocyanatobenzene], propylene glycol monomethacrylate-blocked
- EC Number:
- 923-201-3
- Cas Number:
- 1192143-92-2
- Molecular formula:
- C29H34N2O8 C50H58N4O13 C71H82N6O18 C92H106N8O23 C113H130N10O28
- IUPAC Name:
- Propanol, oxybis-, oligomeric reaction products with 1,1'-methylenebis[isocyanatobenzene], propylene glycol monomethacrylate-blocked
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- other: WISTAR Crl: WI(Han)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Age at study initiation: 8 - 9 weeks (males), 12 - 13 weeks (females)
- Weight at study initiation: 256 - 278 g (males), 211 - 224 g (females)
- Housing: The animals were housed in groups in IVC cages, type III H, polysulphone cages on Altromin saw fibre bedding.
- Diet: Altromin 1324 maintenance diet for rats and mice, ad libitum
- Water: tap water, sulphur acidified to a pH value of approximately 2.8, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES:
From: 16 Aug 2012
To: 30 Aug 2012
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- corn oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: clipped, healthy skin of the dorsal area of the trunk
- % coverage: approximately 10%
- Type of wrap if used: gauze and non-irritant tape, fixed with a semiocclusive dressing
REMOVAL OF TEST SUBSTANCE
- Washing (if done): After an exposure period of 24 h, the residual test substance was removed using the vehicle. - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations were made several times on the day of dosing (especially during the first 30 min until 4 h after application) and once daily thereafter until the end of the study period. The animals were weighed on Day 1 prior to application and on Days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: primary skin irritation (Draize scoring system)
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals survived until the end of the study period.
- Clinical signs:
- other: No signs of sytemic toxicity were observed.
- Gross pathology:
- The necropsy revealed no test substance-related findings.
- Other findings:
- Skin irritation:
No erythema and oedema formation was noticed during the observation period. In 1/5 males, eschar formation was observed on Day 8, that resolved within 24 h (Table 2). In 4/5 females, scratches, eschar formation or wounds were noticed which were fully reversible within the observation period in 3/5 females (Table 3).
Any other information on results incl. tables
Table 1: Absolute Body Weights and Body Weight Gain
Animals |
Body weight (g) |
Increase (%) |
|||
Sex |
Number |
Day 1 |
Day 8 |
Day 15 |
Day 1 - 15 |
male |
21 |
274 |
305 |
339 |
24 |
22 |
264 |
285 |
310 |
17 |
|
23 |
256 |
255 |
273 |
7 |
|
24 |
278 |
291 |
319 |
15 |
|
25 |
270 |
281 |
313 |
16 |
|
female |
26 |
213 |
213 |
219 |
3 |
27 |
224 |
221 |
221 |
-1 |
|
28 |
211 |
215 |
216 |
2 |
|
29 |
212 |
206 |
211 |
0 |
|
30 |
213 |
211 |
215 |
1 |
|
Table 2: Skin irritation – individual data – males
Days after Application |
Animal No. 21 |
Animal No. 22 |
Animal No. 23 |
Animal No. 24 |
Animal No. 25 |
|||||
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
|
2 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
3 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
4 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
5 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
6 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
7 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
8 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es |
0/0 |
nsf |
0/0 |
nsf |
9 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
10 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
11 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
12 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
13 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
14 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
15 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
Comments:
E = erythema, O = oedema; 1, 2, 3, 4 = scoring system laid down in OECD Guideline 404 (Draize scoring system)
es = eschar, s = scratches, es* = eschar on large patches; w = small wounds; w (2) = wound (2 mm diameter) nsf = no specific finding
Table 3: Skin irritation – individual data – females
Days after Application |
Animal No. 26 |
Animal No. 27 |
Animal No. 28 |
Animal No. 29 |
Animal No. 30 |
|||||
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
E/O |
Comments |
|
2 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
3 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
4 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
5 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es* |
0/0 |
es |
6 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
es* |
0/0 |
es |
7 |
0/0 |
s |
0/0 |
s |
0/0 |
nsf |
0/0 |
es* |
0/0 |
nsf |
8 |
0/0 |
w (2) |
0/0 |
es |
0/0 |
nsf |
0/0 |
es* |
0/0 |
nsf |
9 |
0/0 |
w (2) |
0/0 |
es |
0/0 |
nsf |
0/0 |
es* |
0/0 |
nsf |
10 |
0/0 |
w (2) |
0/0 |
es |
0/0 |
nsf |
0/0 |
w |
0/0 |
nsf |
11 |
0/0 |
w (2) |
0/0 |
es |
0/0 |
nsf |
0/0 |
w |
0/0 |
nsf |
12 |
0/0 |
w (2) |
0/0 |
es |
0/0 |
nsf |
0/0 |
w |
0/0 |
nsf |
13 |
0/0 |
w |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
w |
0/0 |
nsf |
14 |
0/0 |
w |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
w |
0/0 |
nsf |
15 |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
nsf |
0/0 |
w |
0/0 |
nsf |
Comments:
E = erythema, O = oedema; 1, 2, 3, 4 = scoring system laid down in OECD Guideline 404 (Draize scoring system)
es = eschar, s = scratches, es* = eschar on large patches; w = small wounds; w (2) = wound (2 mm diameter) nsf = no specific finding
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
